Ohio ST Compr Cancer Ctr James Hosp is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Ohio ST Compr Cancer Ctr James Hosp has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Chronic Lymphocytic Leukemia (CLL).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ohio ST Compr Cancer Ctr James Hosp has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ohio ST Compr Cancer Ctr James Hosp has 2 clinical trials on record, with 1 currently active. Their work covers Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Chronic Lymphocytic Leukemia (CLL).
Ohio ST Compr Cancer Ctr James Hosp has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.